Summary

Persistence Market Research has recently released a comprehensive report on the global Equine Veterinary Therapeutics market. The report delivers an in-depth evaluation of key market dynamics-drivers, trends, opportunities, and restraints-while offering detailed insights into market structure, value chain evolution, and competitive positioning across regions.

Key Insights

・Equine Veterinary Therapeutics Market Size (2026E): US$ 1.8 Bn
・Projected Market Value (2033F): US$ 2.8 Bn
・Global Market Growth Rate (CAGR 2026-2033): 7.5%

Equine Veterinary Therapeutics Market - Report Scope

The equine veterinary therapeutics market encompasses the ecosystem of manufacturers, suppliers, and end-users engaged in the production, distribution, and application of equine veterinary therapeutics products and solutions. The market serves a wide range of end-use industries, and rapid technological advancements alongside evolving end-user requirements are significantly influencing market expansion across major global regions.

Market Growth Drivers

Rising equestrian sports participation and increased awareness of animal health drive demand for preventive and therapeutic equine veterinary services.

Market Restraints

High costs of advanced treatments and specialized medicines limit adoption among horse owners.

Market Opportunities

Emerging technologies like telemedicine, wearable devices, and regenerative therapies offer novel treatment possibilities.

Key Questions Answered in the Report

・What are the major factors driving global demand for equine veterinary therapeutics?
・Which drug type and route of administration segments are witnessing the highest growth in the equine veterinary therapeutics market?
・How is the competitive landscape evolving in the equine veterinary therapeutics market?
・Who are the leading players in the equine veterinary therapeutics market, and what strategies are they adopting?
・What are the emerging trends and long-term growth prospects for the global equine veterinary therapeutics market?

Competitive Intelligence and Business Strategy

Leading players in the equine veterinary therapeutics market are focusing on capacity expansion, product innovation, and strategic partnerships to strengthen their global footprint. Companies are investing in R&D and sustainable practices while pursuing collaborations, mergers, and regional expansion to gain a competitive edge.

Key Companies Profiled

・Merck Animal Heath
・Affymetrix
・Elanco Animal Health
・Zoetis (Pfizer Animal Health)
・Equine Health UK
・PetVivo Holdings, Inc.

Market Segmentation

By Drug Type
・Anti-Inflammatory
・Anti-Infective
・Parasiticides
・Others

By Route of Administration
・Oral
・Parental
・Topical

By Region
・North America
・Europe
・East Asia
・South Asia & Oceania
・Middle East & Africa
・Latin America

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Equine Veterinary Therapeutics Market Snapshot, 2026 and 2033
1.2. Market Opportunity Assessment, 2026-2033, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. Equine Veterinary Therapeutics Market: Value Chain
2.4.1. List of Raw Material Suppliers
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. Profitability Analysis
2.5. Forecast Factors - Relevance and Impact
2.6. Covid-19 Impact Assessment
2.7. PESTLE Analysis
2.8. Porter Five Force's Analysis
2.9. Geopolitical Tensions: Market Impact
2.10. Regulatory and Application Landscape
3. Macro-Economic Factors
3.1. Global Sectorial Outlook
3.2. Global GDP Growth Outlook
3.3. Global Parent Market Overview
4. Price Trend Analysis, 2019-2033
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Prices By Product Type/Composition/Application
4.4. Regional Prices and Product Preferences
5. Global Equine Veterinary Therapeutics Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
5.1. Key Highlights
5.1.1. Market Size and Y-o-Y Growth
5.1.2. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
5.2.1. Historical Market Size Analysis, 2019-2025
5.2.2. Current Market Size Forecast, 2026-2033
5.3. Global Equine Veterinary Therapeutics Market Outlook: Drug Type
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2019-2025
5.3.3. Current Market Size (US$ Mn) Forecast By Drug Type, 2026-2033
5.3.3.1. Anti-Inflammatory
5.3.3.2. Anti-Infective
5.3.3.3. Parasiticides
5.3.3.4. Others
5.4. Market Attractiveness Analysis: Drug Type
5.5. Global Equine Veterinary Therapeutics Market Outlook: Route of Administration
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2019-2025
5.5.3. Current Market Size (US$ Mn) Forecast By Route of Administration, 2026-2033
5.5.3.1. Oral
5.5.3.2. Parental
5.5.3.3. Topical
5.6. Market Attractiveness Analysis: Route of Administration
6. Global Equine Veterinary Therapeutics Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2025
6.3. Current Market Size (US$ Mn) Forecast By Region, 2026-2033
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region
7. North America Equine Veterinary Therapeutics Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
7.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
7.4.1. By Drug Type
7.4.2. By Route of Administration
7.4.3. By Country: U.S. and Canada
7.5. Market Attractiveness Analysis
8. Europe Equine Veterinary Therapeutics Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
8.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
8.4.1. By Drug Type
8.4.2. By Route of Administration
8.4.3. By Country: Germany, Italy, France, U.K., Spain, Russia, Rest of Europe
8.5. Market Attractiveness Analysis
9. East Asia Equine Veterinary Therapeutics Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
9.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
9.4.1. By Drug Type
9.4.2. By Route of Administration
9.4.3. By Country: China, Japan, South Korea
9.5. Market Attractiveness Analysis
10. South Asia and Oceania Equine Veterinary Therapeutics Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
10.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
10.4.1. By Drug Type
10.4.2. By Route of Administration
10.4.3. By Country: India, ASEAN, Oceania, Rest of South Asia
10.5. Market Attractiveness Analysis
11. Latin America Equine Veterinary Therapeutics Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
11.1. Key Highlights
11.2. Pricing Analysis
11.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
11.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
11.4.1. By Drug Type
11.4.2. By Route of Administration
11.4.3. By Country: Brazil, Mexico, Rest of Latin America
11.5. Market Attractiveness Analysis
12. Middle East & Africa Equine Veterinary Therapeutics Market Outlook: Historical (2019-2025) and Forecast (2026-2033)
12.1. Key Highlights
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2025
12.4. Current Market Size (US$ Mn) Forecast By Market Taxonomy, 2026-2033
12.4.1. By Drug Type
12.4.2. By Route of Administration
12.4.3. By Country: GCC Countries, South Africa, Rest of Middle East & Africa
12.5. Market Attractiveness Analysis
13. Competitive Landscape
13.1. Market Share Analysis by Company, 2026
13.2. Competitive Dashboard
13.3. Company Profiles
13.3.1. Merck Animal Heath
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio
13.3.1.3. Financial Overview
13.3.1.4. Business Strategies and Developments
13.3.2. Affymetrix
13.3.2.1. Company Overview
13.3.2.2. Product Portfolio
13.3.2.3. Financial Overview
13.3.2.4. Business Strategies and Developments
13.3.3. Elanco Animal Health
13.3.3.1. Company Overview
13.3.3.2. Product Portfolio
13.3.3.3. Financial Overview
13.3.3.4. Business Strategies and Developments
13.3.4. Zoetis (Pfizer Animal Health)
13.3.4.1. Company Overview
13.3.4.2. Product Portfolio
13.3.4.3. Financial Overview
13.3.4.4. Business Strategies and Developments
13.3.5. Equine Health UK
13.3.5.1. Company Overview
13.3.5.2. Product Portfolio
13.3.5.3. Financial Overview
13.3.5.4. Business Strategies and Developments
13.3.6. PetVivo Holdings, Inc.
13.3.6.1. Company Overview
13.3.6.2. Product Portfolio
13.3.6.3. Financial Overview
13.3.6.4. Business Strategies and Developments
14. Appendix
14.1. Research Methodology
14.2. Report Assumptions
14.3. Acronyms and Abbreviations